Read this before buying Ramsay Health Care shares for its dividend

Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX:RHC ) shares go ex-dividend on Wednesday March 6, 2019. Here's what you need to know.

The Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) share price fell 1.32% on the ASX today to close at $63.03.

If you've been thinking of buying shares in the global hospital group for its growing, fully franked divided, there are a few things you need to know today.

The first is that shares will go ex-dividend on Wednesday, March 6, 2019.  The 'ex-date' is when the shares start selling without the value of its next dividend payment so an investor needs to own the shares before the ex-date to receive the dividend. The dividend will then be paid on Friday, March 29, 2019.

a woman

What is Ramsay Health Care's dividend yield?

At its recent half-year results, Ramsay declared a dividend of 60 cents per share for the half year. This was up 4.3% on the same period in 2018 and at the current share price of $63 per share the company offers a trailing dividend yield of 2.3%, fully franked.

Is the dividend sustainable going forward?

This is a great question to ask before buying any company for its dividend.

At the company's half-year update last week Ramsay presented Net profit after tax (NPAT) of $274 million for the six months to 31 December 2018, up 1.1% on the same period in 2017.

Pleasingly revenue lifted 16% and cash flows from operations lifted 6.5% which is a positive sign for sustaining dividends.

Ramsay has a strong history of earnings and dividend growth and looking forward the group is expecting to achieve its guidance of 'Core' earnings per share (EPS) growth of up to 2% for the full financial year.

Foolish takeaway

I think Ramsay Health Care will be a clear beneficiary of the long-term trend of increasing healthcare expenditure and although its current yield of 2.3% is not earth-shattering, the long-term prospects for increasing distributions to investors would be worth short-listing to my dividend watch-list.

However, there are also several other companies going ex-dividend on 06 March to consider, including:

  • FlexiGroup Limited (ASX: FXL)
  • Event Hospitality and Entertainment Ltd (ASX: EVT)
  • Hansen Technologies Limited (ASX: HSN)

Regan Pearson has no position in any of the stocks mentioned. You can follow him on Twitter @Regan_Invests. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Hansen Technologies. The Motley Fool Australia has recommended FlexiGroup Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two scientists analysing results on a computer screen.
Healthcare Shares

$10,000 invested in Pro Medicus and CSL shares 3 years ago is now worth…

Was I better off investing $10,000 into Pro Medicus or CSL shares three years ago?

Read more »

A share market investment manager monitors share price movements on his mobile phone and laptop
Healthcare Shares

Fund managers are loading up on CSL shares. Here's why

CSL is attracting renewed interest from fundies.

Read more »

Happy businessman fist pumping while looking at a tablet.
Healthcare Shares

Mesoblast wins FDA nod for new Ryoncil potency test

Mesoblast gets FDA approval for a new Ryoncil potency assay, aiming to ensure quality and support product expansion.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces.
Healthcare Shares

Can CSL shares hit $200? 3 things that need to go right

CSL needs to prove its earnings engine is accelerating again, not merely stabilising.

Read more »

Group of doctors celebrate by pumping fists in the air.
Healthcare Shares

Telix Pharmaceuticals vs Ramsay Healthcare: Which ASX healthcare stock made investors richer in 2026?

And find out which has the strongest upside ahead.

Read more »

Buy and sell written on red dice on top of stock market charts.
Broker Notes

Up 98%: Are CSL shares now a buy, hold or sell?

A leading expert provides his forecast for CSL’s rocketing shares.

Read more »

Doctor with stethoscope using a tablet in a hospital.
Broker Notes

What is this broker's view on Telix shares after yesterday's crash?

Here is the latest outlook from Bell Potter.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can CSL continue delivering very healthy returns?

Read more »